Eye Clinic, Multidisciplinary Department of Medical, Surgical and Dental Sciences, University of Campania Luigi Vanvitelli, Naples, Italy.
Eye Clinic, Neuromuscolar and Sense Organs Department, Careggi University Hospital, Florence, Italy.
Invest Ophthalmol Vis Sci. 2022 Feb 1;63(2):13. doi: 10.1167/iovs.63.2.13.
To investigate the course of inherited retinal degenerations (IRD) due to mutations in the RPE65 gene.
This longitudinal multicentric retrospective chart-review study was designed to collect best corrected visual acuity (BCVA), Goldman visual field, optical coherence tomography (OCT), and electroretinography (ERG) measurements. The data, including imaging, were collected using an electronic clinical research form and were reviewed at a single center to improve consistency.
From an overall cohort of 60 Italian patients with RPE65-associated IRD, 43 patients (mean age, 27.8 ± 19.7 years) were included and showed a mean BCVA of 2.0 ± 1.0 logMAR. Time-to-event analysis revealed a median age of 33.8 years and 41.4 years to reach low vision and blindness based on BCVA, respectively. ERG (available for 34 patients) showed undetectable responses in most patients (26; 76.5%). OCT (available for 31 patients) revealed epiretinal membranes in five patients (16.1%). Central foveal thickness significantly decreased with age at a mean annual rate of -0.6%/y (P = 0.044). We identified 43 different variants in the RPE65 gene in the entire cohort. Nine variants were novel. Finally, to assess genotype-phenotype correlations, patients were stratified according to the number of RPE65 loss-of-function (LoF) alleles. Patients without LoF variants showed significantly (P < 0.05) better BCVA compared to patients with one or two LoF alleles.
We described the natural course of RPE65-associated IRD in an Italian cohort showing for the first time a specific genotype-phenotype association. Our findings can contribute to a better management of RPE65-associated IRD patients.
研究 RPE65 基因突变导致的遗传性视网膜退行性疾病(IRD)的病程。
本研究为纵向多中心回顾性图表审查研究,旨在收集最佳矫正视力(BCVA)、Goldman 视野、光学相干断层扫描(OCT)和视网膜电图(ERG)测量值。使用电子临床研究表格收集包括成像在内的数据,并在一个中心进行审核,以提高一致性。
在 60 名意大利 RPE65 相关 IRD 患者的总体队列中,纳入了 43 名患者(平均年龄为 27.8 ± 19.7 岁),平均 BCVA 为 2.0 ± 1.0 logMAR。生存时间分析显示,基于 BCVA,中位数年龄分别为 33.8 岁和 41.4 岁时会发展为低视力和失明。ERG(可用于 34 名患者)显示大多数患者(26 名;76.5%)无法检测到反应。OCT(可用于 31 名患者)显示 5 名患者(16.1%)有视网膜内膜。中央视网膜厚度随年龄以平均每年-0.6%/y 的速度显著降低(P = 0.044)。在整个队列中,我们在 RPE65 基因中发现了 43 种不同的变异。其中 9 种是新的。最后,为了评估基因型-表型相关性,根据 RPE65 功能丧失(LoF)等位基因的数量对患者进行分层。没有 LoF 变异的患者的 BCVA 明显(P < 0.05)优于有一个或两个 LoF 等位基因的患者。
我们描述了意大利队列中 RPE65 相关 IRD 的自然病程,首次显示了特定的基因型-表型关联。我们的研究结果有助于更好地管理 RPE65 相关 IRD 患者。